The Claim
Apigenin inhibits IL-1α-driven activation of the IRAK1/IRAK4/p38-MAPK/NF-κB signaling cascade in senescent human fibroblasts, resulting in reduced expression of SASP factors including IL-6 and CXCL10, without altering senescence markers such as SA-β-gal or growth arrest.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Apigenin blocks a specific inflammatory signaling pathway triggered by IL-1α in aged human skin cells, leading to lower production of inflammatory proteins IL-6 and CXCL10, without changing established markers of cellular aging.
See the scientific wording
Apigenin inhibits IL-1α-driven activation of the IRAK1/IRAK4/p38-MAPK/NF-κB signaling cascade in senescent human fibroblasts, leading to reduced expression of SASP factors such as IL-6 and CXCL10, independent of changes in senescence markers like SA-β-gal or growth arrest.
Apigenin stops a specific inflammatory signal in old cells by blocking key proteins that turn on genes for harmful chemicals, which reduces the release of those chemicals without changing the aging state of the cells.
What the research says
1 studyApigenin, a natural compound in some plants, stops aged human cells from releasing harmful inflammatory signals that can promote cancer — without changing whether the cells are old or stopped dividing.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.